CompletedNot Applicable

Investigational Study With the BD PosiFlush™ SafeScrub on NADs

Austria222 participantsStarted 2024-10-22

Plain-language summary

This study is an investigational study to evaluate the safety and performance of the BD PosiFlush™ SafeScrub on needleless access devices.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Any patient (≥18 years of age) in a high acuity hospital medical or surgical unit regardless of gender, with an eligible in-situ vascular access device and with a needleless access device (NAD). This includes patients who have a current VAD, whether it is newly placed or long-term access as part of their routine medical care. Eligible in-situ vascular access devices are peripheral intravenous catheters (PIVCs), peripherally inserted central catheters (PICCs), central venous catheters (CVCs) and implanted venous access ports. Eligible NADs are stopcocks, Y-sites, and needle-free connectors.
✓. Expected to be available until 2 accesses are completed and for any periodic observation upto 15 min after each access.
✓. Able and willing to provide informed consent or legal authorized representative (LAR) authorized to give consent on behalf of the participant.

Device related adverse events

Timeframe: 15 minutes

NCT IDNCT06604026

SponsorBecton, Dickinson and Company

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-04-30